TCG Crossover Management »

Ocular Therapeutix shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Ocular Therapeutix (OCUL) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Ocular Therapeutix

Tip: Access up to 7 years of quarterly data

All positions including Ocular Therapeutix held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocular Therapeutix by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $48M 5.3M 9.10

More positions owned by TCG Crossover Management

Cg Oncology Comm
Dyne Therapeutics Comm (DYN)
Astria Therapeutics Comm (ATXS)
Silence Therapeutics Adrs (SLN)
Structure Therapeutics Adrs (GPCR)
Aerovate Therapeutics Comm (AVTE)
Inhibrx Comm (INBX)
Keros Therapeutics Comm (KROS)
Geron Corp Comm (GERN)
Savara Comm (SVRA)
Ocular Therapeutix Comm (OCUL)
Cogent Biosciences Comm (COGT)
Edgewise Therapeutics Comm (EWTX)
Mineralys Therapeutics Comm (MLYS)
Madrigal Pharmaceuticals Comm (MDGL)

View all positions for TCG Crossover Management

Top funds holding Ocular Therapeutix

Summer Road
VR Adviser
Deep Track Capital
BlackRock
Vanguard Group
venBio Select Advisor
Opaleye Management
Logos Global Management
Citadel Advisors
TCG Crossover Management
Perceptive Advisors
Longwood Capital Partners
Geode Capital Management
Octagon Capital Advisors
State Street Corporation

View all funds holding Ocular Therapeutix